Form 4: Molina Healthcare CEO Joseph Zubretsky Reports Share Transactions Following PSU Vesting and Restricted Stock Grant
SEC Form 4 Filing
Molina Healthcare's CEO, Joseph Zubretsky, reports the acquisition and disposal of company shares related to performance stock unit vesting, tax withholdings, and a new restricted stock grant.
Summary
- On March 1, 2024, Joseph Zubretsky, the President & CEO of Molina Healthcare, Inc., reported transactions involving the company's common stock.
- These transactions include the acquisition of 68,844 shares upon the vesting of performance stock units (PSUs) granted on March 1, 2021, which vested at 170% achievement level based on the company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.
- A total of 59,443 shares were disposed of to cover withholding taxes related to the vesting of these PSUs and other shares.
- Zubretsky also acquired 16,735 shares of restricted stock under the company's 2019 Equity Incentive Plan, which will vest in one-third increments on March 1, 2025, March 1, 2026, and March 1, 2027.
- Following these transactions, Zubretsky beneficially owns 349,952 shares of Molina Healthcare common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The vesting of PSUs at 170% suggests strong past performance. The new restricted stock grant indicates continued confidence in the company's future.
Positives
- The vesting of performance stock units at 170% suggests strong performance relative to the targets set three years prior.
- The grant of restricted stock aligns the CEO's interests with long-term shareholder value creation.
Future Outlook
The restricted stock units will vest in installments over the next three years, aligning the CEO's compensation with the company's long-term performance.
Industry Context
Executive compensation through equity grants is a common practice in the healthcare industry to incentivize performance and align management's interests with those of shareholders.
Comparison to Industry Standards
- Equity grants are a standard component of executive compensation packages in publicly traded healthcare companies.
- Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also utilize performance-based equity awards and restricted stock units to incentivize their executives.
- The vesting schedules and performance metrics associated with these grants often vary based on company-specific goals and industry benchmarks.
Stakeholder Impact
- Shareholders may view the vesting of PSUs and the grant of restricted stock as positive indicators of management's alignment with their interests.
- Employees may be motivated by the company's achievement of performance targets that led to the PSU vesting.
Key Dates
| Date | Description |
|---|---|
| 2017-10-09 | Date of Limited Power of Attorney for Section 16(a) Filings |
| 2021-03-01 | Date of grant of performance stock units that vested on March 1, 2024 |
| 2024-03-01 | Date of transactions: PSU vesting, tax withholding, and restricted stock grant |
| 2024-03-05 | Date of Form 4 filing |
| 2025-03-01 | First vesting date for one-third of the newly granted restricted stock |
| 2026-03-01 | Second vesting date for one-third of the newly granted restricted stock |
| 2027-03-01 | Final vesting date for one-third of the newly granted restricted stock |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.